Winfield Associates’s National Health Investors NHI Stock Holding History

Winfield Associates’s Portfolio NHI Stock Details NHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-48	Closed	-$4K	–	858
2017 Q2	$4K	Buy	+48	New	+$3.63K	﹤0.01%	582

Other funds holding NHI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Winfield Associates's NHI Position: Q3 2017 in Review

Winfield Associates sold out of National Health Investors (NHI) in Q3 2017, closing a stake of 48 shares — an estimated $4K sold.

Winfield Associates first reported a position in NHI in Q2 2017 and held it in 1 quarter. The position peaked at $4K in Q2 2017. 206 funds tracked by Wall St. Rank hold NHI as of Q3 2017.

Winfield Associates reported no remaining National Health Investors position as of Q3 2017 after selling out during the quarter.
Winfield Associates sold 48 National Health Investors shares in Q3 2017, an estimated $4K.
Winfield Associates first reported a position in National Health Investors in Q2 2017 and held it in 1 quarter.
Winfield Associates's National Health Investors position peaked at $4K in Q2 2017.
206 funds tracked by Wall St. Rank held National Health Investors as of Q3 2017.

Based on Winfield Associates's 13F filing for Q3 2017, filed 6 Nov 2017.